IL162108A0 - Hydroperylene derivatives - Google Patents

Hydroperylene derivatives

Info

Publication number
IL162108A0
IL162108A0 IL16210802A IL16210802A IL162108A0 IL 162108 A0 IL162108 A0 IL 162108A0 IL 16210802 A IL16210802 A IL 16210802A IL 16210802 A IL16210802 A IL 16210802A IL 162108 A0 IL162108 A0 IL 162108A0
Authority
IL
Israel
Prior art keywords
hydroperylene
derivatives
hydroperylene derivatives
illnesses
prophylaxis
Prior art date
Application number
IL16210802A
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL162108A0 publication Critical patent/IL162108A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/34Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

The invention relates to compounds of formula (I) which are suitable for producing medicaments used for the prophylaxis and therapy of illnesses characterised by increased blood platelet aggregation.
IL16210802A 2001-11-28 2002-11-15 Hydroperylene derivatives IL162108A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10158402A DE10158402A1 (en) 2001-11-28 2001-11-28 Hydroperylene derivatives
PCT/EP2002/012802 WO2003045905A1 (en) 2001-11-28 2002-11-15 Hydroperylene derivatives

Publications (1)

Publication Number Publication Date
IL162108A0 true IL162108A0 (en) 2005-11-20

Family

ID=7707291

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16210802A IL162108A0 (en) 2001-11-28 2002-11-15 Hydroperylene derivatives

Country Status (9)

Country Link
EP (1) EP1451151B1 (en)
JP (1) JP4452078B2 (en)
AT (1) ATE420854T1 (en)
AU (1) AU2002358015B2 (en)
CA (1) CA2468181A1 (en)
DE (2) DE10158402A1 (en)
IL (1) IL162108A0 (en)
MX (1) MXPA04004661A (en)
WO (1) WO2003045905A1 (en)

Also Published As

Publication number Publication date
EP1451151A1 (en) 2004-09-01
CA2468181A1 (en) 2003-06-05
AU2002358015B2 (en) 2007-09-20
EP1451151B1 (en) 2009-01-14
MXPA04004661A (en) 2004-08-13
AU2002358015A1 (en) 2003-06-10
DE50213225D1 (en) 2009-03-05
JP4452078B2 (en) 2010-04-21
ATE420854T1 (en) 2009-01-15
JP2005510560A (en) 2005-04-21
DE10158402A1 (en) 2003-06-12
WO2003045905A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MY129422A (en) Medicinal compounds
GB0112348D0 (en) Compounds
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ATE365720T1 (en) AGONISTS OF BETA-ADRENORECEPTORS
JO2764B1 (en) Indole derivatives or benzimidazole derivatives for modulating ikappab kinase
MXPA03010134A (en) Substituted cyclohexane-1,4-diamine derivatives.
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
ES2187300A1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
HK1062888A1 (en) Vinyl phenyl derivatives as glk activators
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
MXPA03012013A (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain.
SE0200920D0 (en) Novel compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MXPA05011707A (en) Substituted dihydrochinazolines having antiviral properties.
MXPA04005886A (en) Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands.
MXPA04003087A (en) Chroman derivatives as 5-hydroxytryptamine-6 ligands.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
MXPA05012679A (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament.
MXPA04004443A (en) Pyrazole derivatives as psychopharmaceuticals.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.